ASX - By Stock
|
DXB |
Re:
Ann: Trading Halt
|
|
faul0038
|
247 |
72K |
2 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
247
|
72K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Interim Analyses of Clinical Trials
|
|
faul0038
|
185 |
48K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
185
|
48K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Interim Analyses of Clinical Trials
|
|
faul0038
|
185 |
48K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
185
|
48K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
faul0038
|
3 |
1.0K |
3 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
3
|
1.0K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
faul0038
|
624 |
194K |
8 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
624
|
194K
|
8
|
|
ASX - By Stock
|
1AD |
Re:
Ann: New malaria inhibiting i-body
|
|
faul0038
|
62 |
16K |
0 |
17/01/24 |
17/01/24 |
ASX - By Stock
|
62
|
16K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
faul0038
|
92 |
34K |
1 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
92
|
34K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
faul0038
|
806 |
274K |
7 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
806
|
274K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Wilsons report - 30c 12 month target
|
|
faul0038
|
5 |
2.6K |
12 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
5
|
2.6K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Wilsons report - 30c 12 month target
|
|
faul0038
|
5 |
2.6K |
6 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
5
|
2.6K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on Equity Raising
|
|
faul0038
|
28 |
9.9K |
1 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
28
|
9.9K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
faul0038
|
423 |
146K |
5 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
423
|
146K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
faul0038
|
423 |
146K |
6 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
423
|
146K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ
|
|
faul0038
|
423 |
146K |
3 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
423
|
146K
|
3
|
|
ASX - General
|
|
Re:
SPP Harvester by OnMarket
|
|
faul0038
|
970 |
262K |
0 |
22/07/23 |
22/07/23 |
ASX - General
|
970
|
262K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AGM recording
|
|
faul0038
|
19 |
6.2K |
4 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
19
|
6.2K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Entitlement offer and Convertible Note to raise $12 million
|
|
faul0038
|
70 |
26K |
11 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
70
|
26K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Wilsons target $18.29 and summary
|
|
faul0038
|
65 |
35K |
10 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
65
|
35K
|
10
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
|
|
faul0038
|
111 |
45K |
3 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
111
|
45K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Entitlement offer and Convertible Note to raise $12 million
|
|
faul0038
|
70 |
26K |
2 |
06/05/23 |
06/05/23 |
ASX - By Stock
|
70
|
26K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
|
|
faul0038
|
111 |
45K |
1 |
06/05/23 |
06/05/23 |
ASX - By Stock
|
111
|
45K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
faul0038
|
946 |
470K |
0 |
14/04/23 |
14/04/23 |
ASX - By Stock
|
946
|
470K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
faul0038
|
9.9K |
4.4M |
8 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
faul0038
|
9.9K |
4.4M |
13 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
13
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
faul0038
|
40 |
9.1K |
0 |
19/03/23 |
19/03/23 |
ASX - By Stock
|
40
|
9.1K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
faul0038
|
40 |
9.1K |
0 |
19/03/23 |
19/03/23 |
ASX - By Stock
|
40
|
9.1K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Fundamental Analysis Discussion Only (IXC Thread)
|
|
faul0038
|
40 |
9.1K |
0 |
19/03/23 |
19/03/23 |
ASX - By Stock
|
40
|
9.1K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Survey of predictions
|
|
faul0038
|
20 |
9.4K |
15 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
20
|
9.4K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
FDA
|
|
faul0038
|
122 |
47K |
9 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
122
|
47K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
7 Days till lift off ! Or earlier ? FDA announcement prediction, nearest to the pin, hour and date AEST ?
|
|
faul0038
|
154 |
75K |
3 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
154
|
75K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price Target IF approved.
|
|
faul0038
|
67 |
34K |
6 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
67
|
34K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Rett Syndrome NDA accepted for Priority Review by FDA
|
|
faul0038
|
163 |
80K |
0 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
163
|
80K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
TROFINETIDE TRIALS UPDATE
|
|
faul0038
|
218 |
130K |
0 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
218
|
130K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
faul0038
|
9.9K |
4.4M |
3 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Briefing
|
|
faul0038
|
27 |
7.4K |
15 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
27
|
7.4K
|
15
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Briefing
|
|
faul0038
|
27 |
7.4K |
3 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
27
|
7.4K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Briefing
|
|
faul0038
|
27 |
7.4K |
1 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
27
|
7.4K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
faul0038
|
9.9K |
4.4M |
1 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: AusBioInvest Presentation, including FSGS recruitment update
|
|
faul0038
|
15 |
6.5K |
13 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
15
|
6.5K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
FDA have accepted filing
|
|
faul0038
|
17 |
8.1K |
6 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
17
|
8.1K
|
6
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Appendix 3Y - David Foster
|
|
faul0038
|
20 |
4.9K |
0 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
20
|
4.9K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
faul0038
|
9.9K |
4.4M |
18 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
18
|
|
ASX - By Stock
|
UWL |
Competing Bid for UWL
|
|
faul0038
|
1 |
908 |
7 |
21/05/22 |
21/05/22 |
ASX - By Stock
|
1
|
908
|
7
|
|
ASX - By Stock
|
UWL |
Re:
Ann: Revised Indicative Bid from Morrison/Brookfield Consortium
|
|
faul0038
|
14 |
6.6K |
1 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
14
|
6.6K
|
1
|
|
ASX - By Stock
|
IMR |
Re:
Ann: Munster University Hospital Performs First iCMR Procesure
|
|
faul0038
|
2 |
1.3K |
1 |
22/02/22 |
22/02/22 |
ASX - By Stock
|
2
|
1.3K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Merger Proposal Update
|
|
faul0038
|
28 |
8.8K |
16 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
28
|
8.8K
|
16
|
|
IPOs
|
|
Re:
Alloggio IPO
|
|
faul0038
|
79 |
42K |
4 |
09/11/21 |
09/11/21 |
IPOs
|
79
|
42K
|
4
|
|
IPOs
|
|
Re:
X2M IPO
|
|
faul0038
|
20 |
13K |
0 |
01/09/21 |
01/09/21 |
IPOs
|
20
|
13K
|
0
|
|
ASX - By Stock
|
X2M |
Re:
IPO - X2M Connect Limited - 10 September 2021 #
|
|
faul0038
|
17 |
14K |
1 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
17
|
14K
|
1
|
|
ASX - By Stock
|
X2M |
Re:
IPO - X2M Connect Limited - 10 September 2021 #
|
|
faul0038
|
17 |
14K |
1 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
17
|
14K
|
1
|
|